{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:27:27Z","timestamp":1790872047361,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["02826-2"],"award-info":[{"award-number":["02826-2"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"name":"George L. Shields Foundation"},{"name":"Bloomfield Family Trust"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jneuroim.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,12]],"date-time":"2018-04-12T13:49:48Z","timestamp":1523540988000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS"],"prefix":"10.1016","volume":"321","author":[{"given":"Michael R.","family":"Pranzatelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth D.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2018.04.007_bb0005","first-page":"234","article-title":"Multiple sclerosis in Israeli children: incidence, and clinical, cerebrospinal fluid and magnetic resonance imaging findings","volume":"14","author":"Achiron","year":"2012","journal-title":"Isr. Med. Assoc. J."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.04.007_bb0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/1352458508098562","article-title":"Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study","volume":"15","author":"Atzori","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis\/sensory neuropathy; a clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"Pt 8","key":"10.1016\/j.jneuroim.2018.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.jneuroim.2018.04.007_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081007","article-title":"Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis","volume":"8","author":"Edwards","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-017-0812-y","article-title":"Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study","volume":"14","author":"Farina","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2018.04.007_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jneuroim.2009.03.006","article-title":"Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome","volume":"210","author":"F\u00fchlhuber","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"Suppl. 3","key":"10.1016\/j.jneuroim.2018.04.007_bb0040","first-page":"S3","article-title":"Freedom from disease activity","volume":"74","author":"Havrdova","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0045","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1212\/WNL.0b013e318296e9c3","article-title":"Autoimmune limbic encephalopathy and anti-Hu antibodies in children without cancer","volume":"80","author":"Honnorat","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2018.04.007_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2015.01.010","article-title":"Distinguishing the cerebrospinal fluid cytokine profile in neuropsychiatric systemic lupus erythematosus from other autoimmune neurological diseases","volume":"157","author":"Ichinose","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jneuroim.2012.08.011","article-title":"Impact of cerebrospinal-fluid oligoclonal immunoglobulin bands and HLA-DRB1 risk alleles on brain magnetic-resonance-imaging lesion load in Swedish multiple sclerosis patients","volume":"254","author":"Karrenbauer","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1212\/WNL.50.1.217","article-title":"Optic neuritis and cytokines: no relation to MRI abnormalities and oligoclonal bands","volume":"50","author":"Kivis\u00e4kk","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jneuroim.2018.04.007_bb0065","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00281-014-0424-x","article-title":"B cells in MS and NMO: pathogenesis and therapy","volume":"36","author":"Krumbholz","year":"2014","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.jneuroim.2018.04.007_bb0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/PAT.0b013e3283511a87","article-title":"Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis","volume":"44","author":"Lin","year":"2012","journal-title":"Pathology"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0075","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1177\/1352458510373112","article-title":"Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta","volume":"16","author":"Lundkvist","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-5728(91)90073-G","article-title":"Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis","volume":"32","author":"Maimone","year":"1991","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"10.1016\/j.jneuroim.2018.04.007_bb0085","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1177\/1352458514538111","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study","volume":"20","author":"Mancuso","year":"2014","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jneuroim.2018.04.007_bb0090","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s12325-014-0167-z","article-title":"No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis","volume":"31","author":"Nixon","year":"2014","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0095","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/WNL.42.10.1931","article-title":"Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients","volume":"42","author":"Peterson","year":"1992","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jneuroim.2018.04.007_bb0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40478-017-0487-8","article-title":"The chronically inflamed central nervous system provides niches for long-lived plasma cells","volume":"5","author":"Pollok","year":"2017","journal-title":"Acta. Neuropathol. Commun."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0105","series-title":"Swaiman's Pediatric Neurology: Principles and Practice","first-page":"938","article-title":"Opsoclonus myoclonus syndrome","author":"Pranzatelli","year":"2018"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0110","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0115","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus","volume":"45","author":"Pranzatelli","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.12.014","article-title":"Key role of CXCL13\/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS","volume":"243","author":"Pranzatelli","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/jir.2012.0132","article-title":"Pediatric reference ranges for proinflammatory and anti-inflammatory cytokines in cerebrospinal fluid and serum by multiplexed immunoassay","volume":"33","author":"Pranzatelli","year":"2013","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2013.01.011","article-title":"Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders","volume":"326","author":"Pranzatelli","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0140","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cyto.2013.05.020","article-title":"CCR7 signaling in pediatric opsoclonus-myoclonus: upregulated serum CCL21 expression is steroid-responsive","volume":"64","author":"Pranzatelli","year":"2013","journal-title":"Cytokine"},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2018.04.007_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.11.004","article-title":"CSF neurofilament light chain is increased in OMS, decreasing with immunotherapy, and other pediatric neuroinflammatory disorders","volume":"266","author":"Pranzatelli","year":"2014","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2018.04.007_bb0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/jnnp.2008.159483","article-title":"Cerebrospinal fluid study in paraneoplastic syndromes","volume":"81","author":"Psimaras","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-016-0785-2","article-title":"BAFF index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset","volume":"14","author":"Puthenparampil","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0165-5728(00)00391-X","article-title":"Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Quantitative evidence of anti-HuD specific IgG-synthesis in the central nervous system","volume":"111","author":"Rauer","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0175","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1177\/1352458509348418","article-title":"Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid","volume":"15","author":"Reiber","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-8749.2012.04443.x","article-title":"Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology","volume":"55","author":"Sinclair","year":"2013","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0185","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1468-1331.2007.01802.x","article-title":"Antigen-specific oligoclonal bands in cerebrospinal fluid and serum from patients with anti-amphiphysin and anti-CV2\/CRMP5 associated paraneoplastic neurological syndromes","volume":"14","author":"Stich","year":"2007","journal-title":"Eur. J. Neurol."},{"issue":"7","key":"10.1016\/j.jneuroim.2018.04.007_bb0190","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/1352458511428465","article-title":"Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients","volume":"18","author":"Von Glehn","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2018.04.007_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/1352458511424903","article-title":"Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands","volume":"18","author":"Vrethem","year":"2012","journal-title":"Mult. Scler. J."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818301127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572818301127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:33:28Z","timestamp":1759048408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572818301127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S0165572818301127"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.007","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of intrathecal oligoclonal band production to inflammatory mediator and immunotherapy response in 208 children with OMS","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}